Cargando…
Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619461/ https://www.ncbi.nlm.nih.gov/pubmed/36134611 http://dx.doi.org/10.1093/infdis/jiac393 |
| _version_ | 1784821269863071744 |
|---|---|
| author | Amano, Masayuki Otsu, Sachiko Ichikawa, Yasuko Higashi-Kuwata, Nobuyo Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki |
| author_facet | Amano, Masayuki Otsu, Sachiko Ichikawa, Yasuko Higashi-Kuwata, Nobuyo Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki |
| author_sort | Amano, Masayuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9619461 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96194612022-11-04 Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine Amano, Masayuki Otsu, Sachiko Ichikawa, Yasuko Higashi-Kuwata, Nobuyo Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki J Infect Dis Letter to the Editor Oxford University Press 2022-09-22 /pmc/articles/PMC9619461/ /pubmed/36134611 http://dx.doi.org/10.1093/infdis/jiac393 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Amano, Masayuki Otsu, Sachiko Ichikawa, Yasuko Higashi-Kuwata, Nobuyo Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title | Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title_full | Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title_fullStr | Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title_full_unstemmed | Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title_short | Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine |
| title_sort | restoration of neutralization activity against omicron ba.2 and ba.5 in older adults and individuals with risk factors following the fourth dose of severe acute respiratory syndrome coronavirus 2 bnt162b2 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619461/ https://www.ncbi.nlm.nih.gov/pubmed/36134611 http://dx.doi.org/10.1093/infdis/jiac393 |
| work_keys_str_mv | AT amanomasayuki restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT otsusachiko restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT ichikawayasuko restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT higashikuwatanobuyo restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT matsushitashuzo restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT shimadashinya restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine AT mitsuyahiroaki restorationofneutralizationactivityagainstomicronba2andba5inolderadultsandindividualswithriskfactorsfollowingthefourthdoseofsevereacuterespiratorysyndromecoronavirus2bnt162b2vaccine |